This activity already occurred and is no longer available.
JNMT (December 2011) The SNM Practice Guideline for Somatostatin Receptor Scintigraphy 2.0
JNMT, December 2011, Volume 39, Number 4

JNMT (December 2011)The SNM Practice Guideline for Somatostatin Receptor Scintigraphy 2.0

JNMT, December 2011, Volume 39, Number 4

Member Fee: Free
Non-Member Fee: $15.00

Release Date: December 1, 2011
Expiration Date: December 31, 2014

California Scope: 0.5 Imaging (I); 0.5 Radiopharmacy and/or Radiation Safety (R)

Helena R. Balon1, Tracy L.Y. Brown2, Stanley J. Goldsmith3, Edward B. Silberstein4, Eric P. Krenning5, Otto Lang6, Gary Dillehay7, Jennifer Tarrance, CNMT1, Matt Johnson, CNMT1, and Michael G. Stabin8

1William Beaumont Hospital, Royal Oak, Michigan; 2University of Arkansas for Medical Sciences, Little Rock, Arkansas; 3New York Hospital–Cornell Medical, New York, New York; 4University of Cincinnati Medical Center, Cincinnati, Ohio; 5Erasmus University Medical Center, Rotterdam, The Netherlands; 63rd Medical School, Charles University, Prague, Czech Republic; 7Northwestern University, Chicago, Illinois; and 8Vanderbilt University Medical Center, Nashville, Tennessee

The purpose of this guideline is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of somatostatin receptor scintigraphy (SRS) with 111In-pentetreotide. The European Association of Nuclear Medicine guideline on 111In-pentetreotide scintigraphy (1) was taken into consideration throughout this guideline. This guideline covers imaging with only 111In-pentetreotide. Imaging with other somatostatin analogs is not a subject of this guideline.

Target Audience
Nuclear Medicine Technologists and any professionals in the nuclear medicine and related fields.

Continuing Education Credit Information

VOICE (Technologists)
The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this journal article for a maximum of 1.0 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A credit. In order to receive CE credit, you must first complete the activity content. When completed, take the post-test assessment.  You must obtain a score of 80% to receive the CE credit.  You will have no more than 3 attempts to successfully complete the post-test. Release Date: December 1, 2011. Expiration Date: December 1, 2014. California Scope: 0.5 Imaging (I) 0.5 Radiopharmacy (R).

Minimum system requirements

Supported Internet Browsers:
- Microsoft Internet Explorer (version 7 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)
- Apple Safari (version 4 or higher)

Plug-in: Adobe Acrobat Reader (

For questions please contact the Education Department at

© 2014 SNMMI. All rights reserved.    Policy on Privacy and Confidentiality: 



Type:     Internet Activity (Enduring Material)
3698 Registered Users